TREATMENT OF RESISTANT ARTERIAL HYPERTENSION
Metaanalyses have demonstrated a linear relationship between level of blood pressure (BP) and risk for cardiovascular events. The prevalence of resistant hypertension in the general population is unknown and vary in the range of 1,9 to 30%. More established approaches, such as low dietary salt and mineralocorticoid receptor blockers are indicated for these patients. New technologies, such as renal denervation and carotid stimulation, may be used in the management of patients with resistant hypertension.
Количество просмотров: 469
Похожие публикации:
REPROGRAMMING EXPERIENCE OF BLOOD MONONUCLEAR CELLS INTO INDUCED PLURIPOTENT STEM CELLS (IPSCS) IN A PATIENT WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)
PATTERNS OF DEVELOPMENT OF PATHOMORPHOLOGICAL TUMOR REGRESS AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC CANCER: EXPERIENCE OF THE NATIONAL RESEARCH ONCOLOGY CENTER
TP53 GENE POLYMORPHISM AND BREAST CANCER RISK IN RADIATION-EXPOSED KAZAKH WOMEN
COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF TRADITIONAL POSTOPERATIVE ANALGESIA AND ESP BLOCK IN RADICAL BILATERAL MASTECTOMY
CURRENT STATUS OF PEDIATRIC THYROID CANCER 14 YEARS AFTER THE FUKUSHIMA NUCLEAR ACCIDENT